4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics Press Release 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital...

4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round Press Release 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round 1 March 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”),...

4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery Press Release 4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery Systematic review and meta-analysis of 149 clinical trials of AAV-based gene...